Enzyme N4BP2 Fuels Cancer's Chaotic DNA Rewiring
Scientists have identified N4BP2, an enzyme responsible for chromothripsis—a chaotic chromosome-shattering event prevalent in approximately one in four cancers—which allows tumors to rapidly adapt and resist treatment. This groundbreaking discovery offers a promising new therapeutic target, as blocking N4BP2 significantly reduced this genomic destruction in laboratory cancer cells.